
IDEX BIOMETRICS
HOME
Biometric Smart Cards
The biometric solutions from IDEX Biometrics — IDEX Pay and IDEX Access — are built on a unified biometric platform, tailored to serve multiple markets.
This flexible solution can integrate various applets to enable payments, crypto wallets, physical and logical access, identity verification, and other authentication services.
- 15 April 2025
Reference is made to IDEX Biometrics ASA’s announcement on 14 April 2025 regarding a notice of large shareholding. By inadvertence, the announcement contained some minor errors in the shareholders name and new number of shares. Please see correct notification below: IDEX Biometrics ASA discloses the following on behalf of a shareholder. Reference is made to the notice by IDEX Biometrics on 11 April 2025 that the Extraordinary General Meeting of the company had, subject to the registration of a share capital reduction, resolved to issue 3,000,000,000 shares in a debt conversion, thereby increasing the number of shares in the company to 3,831,594,232. A close associate of Robert Keith, Charles Street International Ltd., will, subject to the registration of the capital reduction, be allocated 1,000,000,000 shares in the debt conversion and will hold 1,000,000,000 shares in IDEX Biometrics, which will represent 26.10 % of the shares and voting rights in the company. Based on the above, Robert Keith and his close associates, will, subject to the registration of the share capital reduction, hold 1,087,395,479 shares, which will represent 28.38% of the shares and voting rights in the company. About this notice: The information shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5-12 of the STA.
- 7 April 2025
At the close of business on 07 April 2025, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting on 11 April 2025. Total 142,779,329 shares or 17.17% of the share capital and votes, including shares held by Mr. Opstad and close relations. Some of the proxies may include voting instructions. Contact personsMarianne Bøe, Head of Investor Relations, Tel.: +47 918 00186Kristian Flaten, CFO, Tel.: +47 950 92322E-mail: ir@idexbiometrics.com About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit www.idexbiometrics.com (http://www.idexbiometrics.com) About this noticeThis notice was issued by Marianne Bøe, Head of Investor Relations, on 07 April 2024 at 21:15 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to section 4‑2 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5-12 the Norwegian Securities Trading Act.
- 31 March 2025
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT. Oslo, Norway – 31 March 2025 – Reference is made to the stock exchange announcements from IDEX Biometrics ASA (the “Company”) dated 17 September and 12 December 2024 regarding the exercise period for Warrants B (ticker: IDEXS), ISIN NO0013380055, issued in connection with the private placement in September 2024 and subsequent offering in December 2024. The exercise period for Warrants B commenced today, on 31 March 2025, and ends on 11 April 2025 at 16:30 CET. Each Warrant gives the holder a right to subscribe for one new share (“New Share”) in the Company at a subscription price of NOK 0.15. All Warrants B not exercised within this period will lapse without compensation to the holder. Arctic Securities AS is acting as manager in connection with the exercise of Warrants B (the “Manager”). Exercise procedure Warrants are exercised through the submission of a duly completed exercise form for the Warrants (the “Exercise Form”) to the Manager at the address or email address set out in the Prospectus and the Exercise Form and payment of the aggregate subscription price for the New Shares. The Exercise Form can be found at the websites of the Company (https://www.idexbiometrics.com/investors/), and Arctic Securities AS (www.arctic.com/secno/en/offerings). By completing and submitting an Exercise Form, the holder of the relevant Warrants irrevocably undertakes to acquire a number New Shares equal to the number of Warrants exercised at the relevant exercise price. For more information relating to the Warrants, please refer to the Prospectus approved and published by the Company on 13 November 2024. For further information contact: Marianne Bøe, Head of Investor Relations, +47 91800186 Kristian Flaten, CFO, +47 95092322 E-mail:ir@idexbiometrics.com For information about the Warrants please contact the Manager: Arctic Securities AS, tel.: + 47 21 01 30 40 About IDEX Biometrics IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. The company’s solutions provide convenience, security, peace of mind, and seamless user experiences worldwide. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, IDEX Biometrics’ biometric solutions target card-based applications for payments and digital authentication. As an industry enabler, the company partners with leading card manufacturers and technology companies to bring its solutions to market. For more information, please visit www.idexbiometrics.com (https://www.idexbiometrics.com). – IMPORTANT INFORMATION – This announcement does not constitute an offer of securities for sale or a solicitation of an offer to purchase securities of the Company in the United States or any other jurisdiction. The securities of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”). The securities of the Company have not been, and will not be, registered under the U.S. Securities Act. Any sale in the United States of the securities mentioned in this communication will be made solely to “qualified institutional buyers” as defined in Rule 144A under the U.S. Securities Act. No public offering of the securities will be made in the United States. This announcement has been prepared on the basis that any offer of securities in any Member State of the European Economic Area, other than Norway, which has implemented the Prospectus Regulation (EU) (2017/1129, as amended, the “Prospectus Regulation”) (each, a “Relevant Member State”) will be made pursuant to an exemption under the Prospectus Regulation, as implemented in that Relevant Member State, from the requirement to publish a prospectus for offers of securities. Accordingly any person making or intending to make any offer in that Relevant Member State of securities which are the subject of the offering contemplated in this announcement, may only do so in circumstances in which no obligation arises for the Company or any of the Managers to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 16 of the Prospectus Regulation, in each case, in relation to such offer. In the United Kingdom, this announcement is only addressed to and is only directed at Qualified Investors who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”) or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as “Relevant Persons”). This announcement are directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Persons distributing this communication must satisfy themselves that it is lawful to do so. Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as “anticipate”, “believe”, “continue”, “estimate”, “expect”, “intends”, “may”, “should”, “will” and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this announcement speak only as …
- 31 March 2025
At the close of business on 31 March 2025, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting on 11 April 2025. Total 63,760,705 shares or 7.37% of the share capital and votes, including shares held by Mr. Opstad and close relations. Some of the proxies may include voting instructions. Contact personsMarianne Bøe, Head of Investor Relations, Tel.: +47 918 00186Kristian Flaten, CFO, Tel.: +47 950 92322E-mail: ir@idexbiometrics.com About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit www.idexbiometrics.com (http://www.idexbiometrics.com) About this noticeThis notice was issued by Marianne Bøe, Head of Investor Relations, on 31 March 2024 at 21:15 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to section 4‑2 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5-12 the Norwegian Securities Trading Act.
- 24 March 2025
Reference is made to the announcement by IDEX Biometrics ASA on 18 March 2025 regarding the results of the exercise of Warrants A. A total of 17,258 Warrants A were exercised, resulting in an aggregate subscription for 17,258 new shares, each Warrant A having an exercise price of NOK 0.15. The share capital increase has been registered in the Norwegian Register of Business Enterprises. Following the issue, IDEX Biometrics ASA share capital is NOK 124,739,134.80, divided into 831,594,232 shares, each with a nominal value of NOK 0.15. For further information contact: Marianne Bøe, Head of Investor Relations, Tel: +47 91800186 Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@idexbiometrics.com About IDEX Biometrics: IDEX Biometrics ASA (IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit www.idexbiometrics.com . About this notice This notice was published by Kristian Flaten, CFO, 24 March 2025 at 16:35 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12.
- 2 April 2024
In today’s digital age, citizens across the world are concerned about the ownership of identity. Nowadays, almost 90% of individuals think that one of the biggest threats to society is the infringement of someone’s right to privacy. And, as the world becomes more and more digital, this is having a significant impact on how we handle data.
- 3 January 2024
Download our latest eBook and embark on a journey towards a world powered by biometrics. Discover how digital ID offers unparalleled convenience, security, and inclusivity and how biometric smart cards bridge the digital divide for an inclusive digital economy.
- 27 January 2025
IDEX Biometrics, a provider of biometric technology, has entered the Japanese market in collaboration with LIFE CARD, one of the country’s credit card issuers. This partnership marks the introduction of biometric payment cards in Japan, with LIFE CARD aiming for commercial deployment in the first half of 2025. Read more
- 9 January 2025
IDEX Biometrics has received an order from DigAware, a product company of Emnovate, for biometric sensor systems designed for physical access solutions. The systems will serve enterprises in the United States and globally, with biometric authentication executed locally on the card – a security feature that keeps sensitive biometric data contained within the card itself rather than stored on external servers. The agreement includes development of a customized biometric matching solution compatible with DigAware’s card architecture, which incorporates Bluetooth and RFID radios. Development work is scheduled for completion in Q1 2025, after which DigAware plans to purchase 50,000 sensor systems from IDEX Biometrics upon customer acceptance. Read more
- 26 November 2024
Global smart card technology company Biosmart has obtained the Letter of Approval (LoA) from Mastercard for its biometric payment card built on the IDEX Pay platform. Biosmart can now move to industrialized production of biometric payment cards. Biosmart is a Korea based manufacturer with an annual production capacity of 50+ million payment cards. Biosmart is a trusted partner of leading banks in Asia, Middle East, Europe and USA. Read more
- 19 November 2024
IDEX Biometrics has entered into a commercial development agreement with South Korean smart card manufacturer Cellfie Global (formerly ICK) to design, manufacture and market biometric metal and PVC cards for bank and fintech launches in USA, Europe and Asia. IDEX Biometrics brings biometric smart cards to market with Cellfie Global Oslo, Norway, and Seoul, South Korea 19 November 2024 – This gives IDEX Biometrics full coverage across all four card manufacturers in South Korea, representing a production capacity in excess of 100 million smart cards annually, and with world leading metal card manufacturing capabilities. Read more
- 26 August 2024
Norway-based card manufacturer IDEX Biometrics has announced that its IDEX Pay was certified by Visa via the latter’s VBSS biometric payment application. Including the IDEX Biometrics card operating system and a fingerprint sensor with Infineon’s SLC38 secure element, the IDEX Pay biometric solution successfully passed Visa’s certification leveraging Visa’s VBSS biometric payment application. The receipt of the Visa certification follows comprehensive biometric performance testing and ensures that the payment’s scheme functional and security features are met. In addition, the certification confirms that IDEX Pay is prepared for scaled commercialisation on the Visa payment network. Currently having over 3 million Visa cards in circulation and a solid market position in APAC, Latin America, and Africa, the certification supports the capabilities of card manufacturers worldwide. Read more
[ap-twitter-feed-pro]